GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocGo Inc (NAS:DCGO) » Definitions » Beneish M-Score

DocGo (DCGO) Beneish M-Score : -0.71 (As of May. 08, 2024)


View and export this data going back to 2021. Start your Free Trial

What is DocGo Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.71 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for DocGo's Beneish M-Score or its related term are showing as below:

DCGO' s Beneish M-Score Range Over the Past 10 Years
Min: -1.67   Med: -1.19   Max: -0.71
Current: -0.71

During the past 5 years, the highest Beneish M-Score of DocGo was -0.71. The lowest was -1.67. And the median was -1.19.


DocGo Beneish M-Score Historical Data

The historical data trend for DocGo's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocGo Beneish M-Score Chart

DocGo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - - -1.67 -0.71

DocGo Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.67 -0.92 -0.88 -0.27 -0.71

Competitive Comparison of DocGo's Beneish M-Score

For the Medical Care Facilities subindustry, DocGo's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocGo's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocGo's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where DocGo's Beneish M-Score falls into.



DocGo Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of DocGo for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.7956+0.528 * 1.1222+0.404 * 1.0956+0.892 * 1.4172+0.115 * 0.7063
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9234+4.679 * 0.145835-0.327 * 1.2993
=-0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $262.1 Mil.
Revenue was 199.246 + 186.553 + 125.487 + 113.003 = $624.3 Mil.
Gross Profit was 66.686 + 55.051 + 41.869 + 31.776 = $195.4 Mil.
Total Current Assets was $338.9 Mil.
Total Assets was $490.5 Mil.
Property, Plant and Equipment(Net PPE) was $38.4 Mil.
Depreciation, Depletion and Amortization(DDA) was $16.4 Mil.
Selling, General, & Admin. Expense(SGA) was $153.0 Mil.
Total Current Liabilities was $170.1 Mil.
Long-Term Debt & Capital Lease Obligation was $15.2 Mil.
Net Income was 7.57 + 4.765 + -2.011 + -3.466 = $6.9 Mil.
Non Operating Income was 0.516 + 0.103 + -1.109 + 0.045 = $-0.4 Mil.
Cash Flow from Operations was -5.919 + -45.878 + 10.693 + -23.118 = $-64.2 Mil.
Total Receivables was $103.0 Mil.
Revenue was 108.785 + 104.32 + 109.519 + 117.892 = $440.5 Mil.
Gross Profit was 42.409 + 33.065 + 39.343 + 39.904 = $154.7 Mil.
Total Current Assets was $271.1 Mil.
Total Assets was $393.3 Mil.
Property, Plant and Equipment(Net PPE) was $39.4 Mil.
Depreciation, Depletion and Amortization(DDA) was $10.6 Mil.
Selling, General, & Admin. Expense(SGA) was $116.9 Mil.
Total Current Liabilities was $100.2 Mil.
Long-Term Debt & Capital Lease Obligation was $14.2 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(262.083 / 624.289) / (102.995 / 440.516)
=0.41981 / 0.233805
=1.7956

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(154.721 / 440.516) / (195.382 / 624.289)
=0.351227 / 0.312967
=1.1222

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (338.87 + 38.42) / 490.452) / (1 - (271.081 + 39.372) / 393.278)
=0.23073 / 0.210602
=1.0956

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=624.289 / 440.516
=1.4172

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(10.566 / (10.566 + 39.372)) / (16.431 / (16.431 + 38.42))
=0.211582 / 0.299557
=0.7063

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(153.036 / 624.289) / (116.94 / 440.516)
=0.245136 / 0.265461
=0.9234

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((15.162 + 170.119) / 490.452) / ((14.192 + 100.158) / 393.278)
=0.377776 / 0.290761
=1.2993

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(6.858 - -0.445 - -64.222) / 490.452
=0.145835

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

DocGo has a M-score of -0.71 signals that the company is likely to be a manipulator.


DocGo (DCGO) Business Description

Traded in Other Exchanges
N/A
Address
35 West 35th Street, Floor 6, New York, NY, USA, 10001
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. DocGo is disrupting the traditional four-wall healthcare system by providing care at the scale of humanity. Its technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace.
Executives
Stephen Sugrue officer: Chief Compliance Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Lee Bienstock officer: Chief Operating Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Ely D Tendler director, officer: General Counsel, Secretary STRATEGIC AND LEGAL SERVICES, PLLC, 54 LAWRENCE AVENUE, LAWRENCE NY 11559
Anthony Capone officer: President 106 DUANE ST., #3, NEW YORK NY 10007
Adriaan Stephanus Oberholzer officer: Chief Financial Officer 35 W 35TH STREET, 6TH FLOOR, NEW YORK NY 10001
James M Travers director C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Etalvina Leite director 5477 VIA NICOLA, NEWBURY PARK CA 91320
Michael J Burdiek director 39 PARKER, IRVINE CA 92618
Ira Smedra director 401 N. JUNE STREET, LOS ANGELES CA 90004
Mark Do Merlin officer: CMO, Ambulnz Holdings, LLC 35 W 35TH STREET, NEW YORK NY 10001
Michael S. Witkowski officer: Chief Compliance Officer PO BOX 10482, NEWBURGH NY 12552
Christopher Fillo director 3110 MAIN STREET, SUITE 310, SANTA MONICA CA 90405
Norman Rosenberg officer: CFO, Ambulnz Holdings, LLC 51 MOUNTAIN AVENUE, MONSEY NY 10952
Stanley Vashovsky director, 10 percent owner, officer: Chief Executive Officer 763 RALEIGH STREET, WOODMERE NY 11598
Steven Katz director 20 REBEL RUN DR, EAST BRUNSWICK NJ 08816

DocGo (DCGO) Headlines

From GuruFocus